Skip to main content
Log in

Pharmacokinetic data processed by microcomputer for the formulation of optimal drug dosage form

  • Review Paper
  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

Microcomputers have been used in pharmacokinetics for several years, but their use in the area of formulation is a new application.

By using appropriate data on the drug, the dosage form required and its mechanism of absorption and clearance, microcomputers can systematize and speed-up formulation, simplify manufacturing processes and, through simulated models and plasma level predictions, reduce the number of bioavailability studies needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aiache J.-M., Devissaguet J.-P. and Guyot-Hermann A.-M. (1982): Galenica 2, Biopharmacie. 2ème Ed. Lavoisier, Paris.

    Google Scholar 

  2. Ritschel W.A. (1980): Handbook of basic pharmacokinetics. Drug Intelligence Publications, Hamilton.

    Google Scholar 

  3. Wagner J.-G. (1975): Fundamentals of clinical pharmacokinetics. Drug Intelligence Publications, Hamilton.

    Google Scholar 

  4. Metzler CM. (1975): A user’s manual to ‘nonlin’. The Upjohn Company, Kalamazoo, Michigan.

    Google Scholar 

  5. Peck C.C. (1979): Non linear least- squares regression programs for microcomputers. J. Pharmacokin. Biopharm.,7(5), 537–541.

    Article  CAS  Google Scholar 

  6. Koeppe P. (1980): A program for non linear regression analysis to be used on desk-top computers. Computer programs in Biomedicine,12, 121–128.

    Article  CAS  PubMed  Google Scholar 

  7. Riegelman S. and Upton R.A. (1979): In vitro and in vivo bioavailability correlation. Drug Absorption, Prescott L.F. and Nimmo W.S. Ed.,2, 297.

    Google Scholar 

  8. Guitard P. (1980): Simulation du niveau plasmatique donné par une forme à action prolongée. Cas d’une ciné tique de dissolution quelconque. 2ème Congrès international de technologie pharmaceutique. APGI Paris 3–5 juin 1980, 219.

  9. Steinbach D., Thoma K., Moeller H. and Stenzhorn G. (1980): Evaluation of pharmaceutical availability from the calculation of drug levels and release profiles. Int. J. Pharm.,4, 327.

    Article  CAS  Google Scholar 

  10. Moeller H. (1981): Comparative evaluation ofin vitro andin vivo drug release of depot preparation. 1er Congrès Européen de biopharmacie et pharmacocinétique. Clermont-Ferrand, Avril 1981, Ed. Lavpoisier, Paris.

    Google Scholar 

  11. Guerten D. et Jaminet F. (1981): Méthode générale de simulation des taux sanguins à partir de données de dissolution: une dose unique. Pharma. Acta Helv.,56, 276.

    Google Scholar 

  12. Guerten D. et Jaminet F. (1981): Méthode générale de simulation des taux sanguins à partir de données de dissolution: doses multiples. Pharma. Acta Helv.,56, 314.

    Google Scholar 

  13. Riegelman S. and Collier P. (1980): The application of statistical moment theory to the evaluation ofin vivo dissolution time and absorption time. J. Pharmacokin. Biopharm.,8, 509.

    Article  CAS  Google Scholar 

  14. Nelson E. (1957): A note on mathematics of oral sustained release products. J. Amer. Pharm. Assoc. (Sci. Ed),46, 572.

    Article  CAS  Google Scholar 

  15. Himmelblau D.M. (1972): Applied non linear programming. MacGraw Hill, New York.

    Google Scholar 

  16. Wiegand R.G. and Taylor J.D. (1960): Kinetics of plasma drug levels after sustained release dosage. Biochem. Pharmacol.,3, 256.

    Article  CAS  PubMed  Google Scholar 

  17. Wagner J.G. (1974): Application of the Wagner-Nelson absorption method to the two-compartment open model. J. Pharmacokin. Biopharm.,2, 469.

    Article  CAS  Google Scholar 

  18. Robinson J.R. and Erikson S.P. (1966): Theoretical formulation of sustained release dosage forms. J. Pharm. Sci.,55, 1254.

    Article  CAS  PubMed  Google Scholar 

  19. Aiache J.-M. et Dubray M. (1981): Formulation et ordinateur. Bulletin Technique Gattefossé, 13.

  20. Guerten D., Dresse A. et Jaminet F. (1981): Profil de dissolution et prévision des taux sanguins d’une forme à action prolongée de theophylline. Comparaison avec des résultatsin vivo. 1 er Congrès Européen de biopharmacie et pharmacocinétique. Clermont-Ferrand. Avril 1981, Ed. Lavoisier, Paris.

    Google Scholar 

  21. Kaplan S.A. and Jack M.L. (1980): Pharmacokinetics as a tool in drug development. Progress in Drug Metabolism,4, 1.

    CAS  Google Scholar 

  22. Thebault J.-J., Aiache J.-M., Darbeau D. and Le Bastard B. (1981): Bioavailability of a long lasting formulation of dihydroergotamine in man. 1 er Congrès Européen de biopharmacie et pharmacocinétique. Clermont-Ferrand. Avril 1981, Ed. Lavoisier, Paris.

    Google Scholar 

  23. Aiache J.-M., Pradat S. et Pognat J.-F. (1981): Influence du méthyl-sulfate de tiemonium sur l’absorption gastrointestinale d l’aspirine. 1er Congrès Européen de biopharmacie et pharmacocinétique. rmont-Ferrand. Avril 1981, Ed. Lavoisier, Paris.

    Google Scholar 

  24. Langenbucher F. (1982): Numerical convolution/deconvolution as a tool for correlatingin vitro within vivo drug availability. Pharm. Ind.,44(11), 1166–1172.

    CAS  Google Scholar 

  25. Bindschaedler C. and Gurny R. (1982): Optimisation de formulations pharmaceutiques par la méthode du Simplex au moyen d’une calculatrice TI 59. Pharm. Acta Halv.,57(9), 251–255.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Plenary lecture at the 3rd International Symposium on Biopharmaceutics and Pharmacokinetics, 1982, Strebske Plezo, Czechoslovakia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aiache, J.M., Turlier, M. & Tanguy, A. Pharmacokinetic data processed by microcomputer for the formulation of optimal drug dosage form. European Journal of Drug Metabolism and Pharmacokinetics 9, 89–102 (1984). https://doi.org/10.1007/BF03189611

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03189611

Key words

Navigation